Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Gains from Investment Securities (2023 - 2025)

Cardiff Oncology (CRDF) has disclosed Gains from Investment Securities for 8 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 40.87% to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, down 40.87% year-over-year, with the annual reading at $4.9 million for FY2025, 40.87% down from the prior year.
  • Gains from Investment Securities hit $4.9 million in Q4 2025 for Cardiff Oncology, up from $4.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $8.3 million in Q3 2024 to a low of $293.0 in Q2 2025.
  • Historically, Gains from Investment Securities has averaged $4.8 million across 3 years, with a median of $4.9 million in 2025.
  • Biggest five-year swings in Gains from Investment Securities: rose 25.32% in 2024 and later tumbled 43.61% in 2025.
  • Year by year, Gains from Investment Securities stood at $6.7 million in 2023, then grew by 25.32% to $8.3 million in 2024, then crashed by 40.87% to $4.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CRDF at $4.9 million in Q4 2025, $4.7 million in Q3 2025, and $293.0 in Q2 2025.